SlovakNews

Science & Tech · United States of America, Germany

Deisseroth, Hegemann and Nagel win medicine Nobel for optogenetics

The 2026 prize recognises discoveries that enabled light-based control of selected nerve cells. The method is widely used in laboratories and has been tested experimentally in people with an inherited form of blindness, but no established therapy is documented.

Live Version: 4Sources: 16Perspectives: 4Updated:

Listen to the story

Short version

0:000:53
Tap to zoom, Esc to close
Foto: France 24 · source

What's new

  • Karl Deisseroth said learning of the award was "very disorienting" and that he got no real sleep before taking a string of celebratory calls, The Associated Press reported.
  • Deisseroth, a Stanford physician-scientist and psychiatrist who treats patients with autism and depression, then made his children's school lunches before they woke for school.
  • Michelle Monje-Deisseroth, his wife, who works as an HHMI investigator and treats children with cancer at Stanford, pointed out that several other Nobel winners also live in their university housing community.
  • The three laureates share a prize of 12 million Swedish kronor.

On Oct. 5, the Karolinska Institutet’s Nobel Assembly in Stockholm jointly awarded the 2026 prize in physiology or medicine to Georg Nagel, Peter Hegemann and Karl Deisseroth. The award recognises discoveries involving light-gated ion channels and optogenetics, a method researchers use to control selected nerve cells with light and investigate how brain circuits shape memories, feelings and behaviour.1246

Infographic

Deisseroth, Hegemann and Nagel win medicine Nobel for optogenetics. Sources: Deutsche Welle, NPR, BBC and others. Nobel Prize 2026. Oct. 5, 2026. Karolinska Institutet announces the three laureates. Perlmann reaches all three laureates by phone. Dec. 10, 2026. Nobel ceremonies held in Stockholm. Light shines on nerve cell. Light-sensitive ion channel opens. Nerve cell activity is controlled. Method tested in retinitis pigmentosa patients. 12 million kronor. Total prize money. Dec. 10. Diplomas and gold medals from the king. Stockholm
Built from the article's facts; every word on it is checked.

A light-controlled neural switch

Optogenetics combines light with genetic modification to activate or silence selected nerve cells. Using this approach, scientists can activate or suppress specific brain pathways, helping them chart neural activity and assess what distinct neuron classes do. The Nobel committee said the technology is used in laboratories around the world.123

The work began with light-sensitive proteins in the single-celled alga Chlamydomonas. Hegemann and colleagues showed that light caused a rapid flow of ions, and Hegemann and Nagel characterised two light-sensitive genes and the proteins now known as channelrhodopsins. These proteins open ion channels when illuminated, providing the molecular basis for optogenetics.356

Deisseroth and colleagues showed that channelrhodopsins function in neurons and that the resulting ion flows can become nerve impulses. His team demonstrated light-triggered signalling in rat nerve cells, and subsequent work enabled researchers to control neurons in living mice. Compact light sources and flexible fibre optics later made experiments possible in freely moving animals.15614

The resulting technique gave scientists precise control over selected populations of neurons. Researchers have used light-controlled circuits in animals to evoke memories, produce feelings and prompt behaviours, while studying the neural pathways involved. Per Svenningsson, who leads the Nobel Committee for Physiology or Medicine, said optogenetics enables forms of brain mapping that had once seemed unimaginable.349

From laboratory tool to medical research

The Nobel Assembly said optogenetics had fundamentally changed understanding of the brain. The method has helped researchers identify circuits associated with particular memories, emotions and behaviours, including circuits relevant to neurological and psychiatric disorders. It has also allowed scientists to examine the types of neurons involved in those conditions.13

Potential medical applications remain under investigation. Researchers are exploring vision restoration and possible uses involving depression, addiction, dementia, Parkinson’s disease and epilepsy. In an interview with WBUR, Deisseroth said optogenetics had been tested in people with retinitis pigmentosa, restoring light sensitivity and allowing some participants to see things they previously could not. This remains experimental, and the dossier does not establish an effective clinical therapy or widespread medical use.11113

Deisseroth works at Stanford University in California; Hegemann is at Berlin's Humboldt University; and Nagel is affiliated with Germany's University of Würzburg. Thomas Perlmann, the medicine Nobel committee's secretary, said he spoke with each of the three winners by phone on the announcement day.2

The prize totals 12 million Swedish kronor, equivalent to just over €1 million or about $1.2 million. It opened the week of Nobel announcements, with the physics, chemistry, literature and peace prizes to follow and the Nobel Memorial Prize in Economic Sciences scheduled for Oct. 12. The medicine laureates are due to receive diplomas and gold medals from Sweden’s king at a ceremony in Stockholm on Dec. 10.1212

A Nobel morning in Stanford

Karl Deisseroth learned of the prize at his home near Stanford University, where the Nobel Assembly reached him by phone. He called the experience "very disorienting" and said he got no real sleep afterward, spending the morning taking congratulatory calls and media interviews.812

After roughly an hour, Deisseroth paused to make school lunches before his children woke up, with The Associated Press present at the family home. His wife Michelle Monje-Deisseroth, a Stanford pediatric neuro-oncologist and HHMI investigator, remarked that their faculty housing area already includes a number of other Nobel Prize winners. Deisseroth described himself as a physician-scientist and psychiatrist who treats patients with autism and depression, in addition to his basic-science work on the brain.8

Why it matters

Two laureates work at German universities, placing European institutions at the centre of a technology widely used to study brain circuits. Deisseroth said optogenetics had restored some light sensitivity in experimental work involving people with retinitis pigmentosa, but the dossier does not establish an effective clinical therapy or broad medical use.1211

Videos

Nobel Medicine Prize 2026: Deisseroth, Hegemann & Nagel Win For Optogenetics | N18G · CNBC-TV18
2026 Nobel Prize in Medicine Goes to Three Scientists for Optogenetics Breakthrough · OTV
Nobel Prize in Medicine 2026: How Light Can Control the Brain | Optogenetics Explained · Not So Complicated
LIVE: Karolinska Institute Announces Nobel Prize 2026 in Medicine or Physiology | APT · APT
🔴LIVE: Nobel Prize 2026: Medicine Laureate Revealed as Nobel Week Begins in Stockholm | AC1W · News Central
🔴LIVE : 2026 Nobel Prize in Medicine Announced in Stockholm | AR112 · POTUS Tracker

Related stories

Version history

  1. version 4 · Added new reporting on Karl Deisseroth's personal reaction and morning routine after learning he had won the Nobel Prize.
  2. version 3 · The update adds reported human testing in retinitis pigmentosa and clarifies how channelrhodopsins convert light-driven ion flows into neural signals.
  3. version 2 · The update fixes the lede’s date, adds details of the Dec. 10 presentation and clarifies the technical and safety barriers facing clinical use.
  4. version 1 ·